Flow Cytometric Measurement of ABO Antibodies in ABO-Incompatible Living Donor Kidney Transplantation

Authors:
  • PVPiero V. Valli
    Piero V. Valli
  • ASAstrid Starke
    Astrid Starke
  • RMRegula J. Mueller
    Regula J. Mueller
  • TFThomas Fehr
    Thomas Fehr
  • MCMarija Cesar-Özpamir
    Marija Cesar-Özpamir
  • USUrs Schanz
    Urs Schanz
  • MWMarkus Weber
    Markus Weber
  • RWRudolf P. Wüthrich
    Rudolf P. Wüthrich
  • GSGeorg Stussi
    Georg Stussi

Abstract
Due to different detection methods, a comparison of anti-A/B antibody (Ab) levels among transplantation centers after living donor ABO-incompatible kidney transplantation is problematic. In the present study, anti-A/B Ab levels were determined prior to, and after, blood group A-to-O kidney transplantation using a recently established semiquantitative flow cytometry-based method, ABO fluorescence-activated cell sorting (ABO-FACS), and compared with standard agglutination titers and indirect antiglobulin testing. Pretransplant agglutination titers were reduced from 1:64 to 1:4, by a total of 14 Glycosorb A column immunoadsorptions (IADSs). Compared with the agglutination titers, antidonor immunoglobulin (Ig) M ABO-FACS mean fluorescence intensity ratios (MFIRs) decreased faster and remained low. No difference was observed using donor type or third-party A red blood cells (RBCs) for the ABO-FACS. Glycosorb A columns were not specific, also reducing anti-B and antiporcine IgM levels, which was confirmed by detecting anti-A/B and antiporcine Abs in the column eluates. In conclusion, analysis of pre- and posttransplant Abs from ABO-incompatible kidney transplant recipients by ABO-FACS allows a better understanding of Ab kinetics, which may improve the design of future IADS protocols.

This publication has 16 references indexed in Scilit: